From new partnerships to product launches, here are 12 key developments in orthobiologics during the first quarter of 2025. 1. Medtronic and Kuros Biosciences signed a strategic agreement to support ...

As part of this collaboration, Kolosis has grown the portfolio of MTF Biologics allograft solutions it represents and distributes to include DBX® Mix and DBX® Putty, providing a variety of ...